helpline 01494 601 400
enquiries 01494 601 300

sodium valproate

Clare Pelham comments on new sodium valproate regulations

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

Our CEO Clare Pelham, a member of the Sodium Valproate Expert Working Group, commented on the news of the new regulations surrounding sodium valproate.

Charity tells health secretary new drug regulations could fail without public campaign

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

Epilepsy Society today welcomes new regulatory measures to stop babies being born with avoidable disabilities after being exposed to the drug, sodium valproate, in the womb.But the charity cautions that unless the regulations are backed by a public communications campaign, the long-fought-for measures may not reach those women and girls who have no option but to take the drug.

concerns around sodium valproate

Information about and concerns around the anti-epileptic drug sodium valproate.

Epilepsy Society welcomes new measures to ensure no babies are exposed to sodium valproate during pregnancy

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

Epilepsy Society's chief executive Clare Pelham has called today's announcement of new regulatory measures around sodium valproate, 'a landmark moment for all women who have ever been prescribed the epilepsy drug.'

Emma Friedmann and the sodium valproate announcement

Emma Friedmann is a parent carer of her 19 year old son who has fetal valproate syndrome. On the 21st February, she attended parliament when the government announced their decision to review handling of concerns around sodium valproate.

 

Epilepsy Society praises Government decision to review handling of concerns around sodium valproate

Jeremy Hunt is wearing a blue suit and addressing parliament at Prime Minister's Questions.

Epilepsy Society's chief executive Clare Pelham has praised the Government's decision to announce a forward-looking review that will address the way the healthcare system has handled the concerns of patients in its care and make certain that lessons are learned and history does not repeat itself.

EMA publishes recommendations on sodium valproate

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

New measures to avoid the exposure of unborn babies to the epilepsy drug, sodium valproate have been announced by the safety committee of the European Medicines Agency (EMA).

Why mums with epilepsy get my #votesforwomen

Epilepsy Society's chief executive Clare Pelham explains why mothers who have campaigned relentlessly about equality in women's health, are her inspiration as we celebrate #VotesforWomen

How you helped our sodium valproate campaign by filling in our survey

Our content manager, Nicola Swanborough, explains how our sodium valproate survey helped us raise awareness of risks associated with the drug in the media, parliament and with Government.

Arlene Foster and DUP support Epilepsy Society sodium valproate campaign

Arlene Foster is wearing a smart red jacket. Her short, brown hair is swept to one side and she is smiling.

Arlene Foster, leader of the Democratic Unionist Party and First Minister of Northern Ireland has pledged her support for Epilepsy Society's campaign to ensure mandatory reviews for all women and girls of childbearing who take sodium valproate.

Pages

Subscribe to RSS - sodium valproate